http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1161439-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc2f7134efa50484bb359fda73782848
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4873
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
filingDate 1967-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1969-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1161439-A
titleOfInvention Pharmaceutical Compositions
abstract 1,161,439. Pharmaceutical preparations. CIBA Ltd. 4 Dec., 1967 [8 Dec., 1966], No. 55067/67. Heading A5B. Pharmaceutical preparations for the treatment of digestive disorders contain 4,7-.phenanthroline-5,6-quinone in admixutre or conjunction with pancreatin, bromelin, dehydr.ocholic acid and 7-iodo-5-chloro-8-hydroxyquinoline and a pharmaceutical carrier suitable for oral administration. The preparations may be administered orally in the form of a dragee preferably having three-stages comprising an inside core containing 4,7-phenanthroline-5,6-quinone and 7-iodo-5-ohloro-8- hydroxyquinoline, an enveloping core layer containing pancreatin and dehydrocholic acid, this composite core being enveloped by a substance that resists gastric fluid and decomposes in an alkaline medium e.g. cellulose acetate/phthalate lacquer, an outer dragee layer containing bromelin and finally a sugar coat. Cysteine hydrochloride may be present in the preparations.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5597564-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5928640-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9400147-A1
priorityDate 1966-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID181977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452063286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6674
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2788
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587756

Total number of triples: 30.